A detailed history of Bank Of America Corp transactions in Precigen, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 185,674 shares of PGEN stock, worth $139,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,674
Previous 167,320 10.97%
Holding current value
$139,255
Previous $264,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.91 - $1.88 $16,702 - $34,505
18,354 Added 10.97%
185,674 $176,000
Q2 2024

Aug 14, 2024

BUY
$1.27 - $1.75 $44,615 - $61,477
35,130 Added 26.58%
167,320 $264,000
Q1 2024

May 15, 2024

SELL
$1.21 - $1.75 $274,694 - $397,285
-227,020 Reduced 63.2%
132,190 $191,000
Q4 2023

Feb 14, 2024

BUY
$0.89 - $1.41 $148,342 - $235,014
166,677 Added 86.57%
359,210 $481,000
Q2 2023

Aug 14, 2023

SELL
$0.96 - $1.4 $1.07 Million - $1.57 Million
-1,117,878 Reduced 85.31%
192,533 $221,000
Q1 2023

May 12, 2023

BUY
$0.88 - $2.19 $1.05 Million - $2.62 Million
1,198,195 Added 1067.76%
1,310,411 $1.39 Million
Q4 2022

Feb 10, 2023

BUY
$1.27 - $2.26 $21,910 - $38,989
17,252 Added 18.17%
112,216 $170,000
Q3 2022

Nov 14, 2022

BUY
$1.41 - $2.79 $57,420 - $113,619
40,724 Added 75.08%
94,964 $201,000
Q2 2022

Aug 12, 2022

BUY
$1.15 - $2.53 $13,993 - $30,785
12,168 Added 28.92%
54,240 $72,000
Q1 2022

May 16, 2022

SELL
$1.91 - $3.98 $366,949 - $764,637
-192,120 Reduced 82.04%
42,072 $89,000
Q4 2021

Feb 08, 2022

BUY
$3.53 - $5.5 $607,685 - $946,819
172,149 Added 277.47%
234,192 $868,000
Q3 2021

Nov 15, 2021

BUY
$4.99 - $6.55 $29,760 - $39,064
5,964 Added 10.63%
62,043 $309,000
Q2 2021

Sep 13, 2021

BUY
$6.24 - $8.22 $349,932 - $460,969
56,079 New
56,079 $365,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $156M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.